Dulera approved for the treatment of asthma - ONA
Links shared publicly online about this topic.
- 1,071total visits
Dulera approved for the treatment of asthma - ONA
View full resource at oncologynurseadvisor.com
Tags: Asthma, FDA, Nasonex, Merck & Co., Dulera
Most Recently Shared on June 24, 2010 at 3:33 pm By:
Dulera approved for the treatment of asthma http://goo.gl/fb/9fcWR
Every Day, Asthma | PhRMA
phrma.org — “For me certain things seem to happen every day.I hit the snooze button one too many times and spend the rest of the morning trying not to be late to work.I somehow manage to make it to my Metro stop just as my train pulls away.And there are never enough hours in the day to do everything I would like to get done.There are also certain things that happen every day in regards to asthma in the U.S., according to the Asthma and Allergy Foundation of America (AAFA)” View full resource at phrma.org
Most Recently Shared on March 23, 2012 at 1:49 pm By:
#Biopharma researchers work 2 find treatments 4 #asthma every day; 74 #MedsInDev are in trial/awaiting FDA approval http://t.co/TMzcftry
FDA approves Allergan's BOTOX to treat specific form of urinary incontinence
news-medical.net — “Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 5:25 am By:
Obesity News: FDA approves Allergan's BOTOX to treat specific form of urinary incontinence: Allergan, Inc. tod... http://t.co/PUWqG8S
Heat Treatment Offers New Hope For Asthma : Healthymagination
healthymagination.com — “Healthymagination is a shared commitment to creating better health for more people. Together.” View full resource at healthymagination.com
Most Recently Shared on November 10, 2010 at 5:32 pm By:
Recently approved by the FDA, bronchial thermoplasty may improve the quality of life for ppl w/asthma http://su.pr/1ZaamB #healthymagination
Bronchial Thermoplasty
btforasthma.com — “Bronchial thermoplasty delivered by the Alair System is the first non-drug asthma therapy approved by the Food and Drug Administration (FDA) for the treatment of severe persistent asthma in adults 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long acting beta agonists.” View full resource at btforasthma.com
Most Recently Shared on November 1, 2010 at 9:43 pm By:
The OSU Asthma Center is now approved to begin our bronchial thermoplasty (BT) program. BT is an FDA-approved... http://fb.me/LmjZtTBw
Asthma UK Comment On Final NICE Determination On Xolair For 6-11s - QualityPoint Technologies
qualitypointtech.net — “Dr Mike Thomas, Chief Medical Adviser to Asthma UK, said: 'Hundreds of children across England with the most severe, allergic asthma will now be denied a pioneering treatment that could free them from crippling daily asthma symptoms, endless trips to hospital and huge amounts of time off school. 'As the Scottish Medicines Consortium (SMC) has already approved omalizumab (Xolair) for use in children aged 6-11 in Scotland, patients will once again be faced with a treatment postcode lottery dependi” View full resource at qualitypointtech.net
Most Recently Shared on August 15, 2010 at 11:54 am By:
Asthma UK Comment On Final NICE Determination On Xolair For 6-11s: Dr Mike Thomas, Chief Medical Adviser to Asthma... http://bit.ly/9jCOE7
DULERA 100/5 - New Product Releases - MPR
empr.com — “Maintenance treatment of asthma in patients not adequately controlled on other asthma-controller medications or whose disease severity warrants initiation of both an inhaled steroid and a long acting 2-agonist.” View full resource at empr.com
Most Recently Shared on August 6, 2010 at 1:15 pm By:
MPR News: DULERA 100/5: Mometasone furoate 100mcg, formoterol fumarate dihydrate 5mcg; per inh; metered-dose inhal... http://bit.ly/bbyuj1
N30 Pharma Announces FDA Approval To Initiate Phase 1 Clinical Trial For First-in-Class Drug - QualityPoint Technologies
qualitypointtech.net — “N30 Pharmaceuticals, LLC announced the approval of its Investigational New Drug Application for N6022 by the U.S. Food and Drug Administration. N6022, a first-in-class inhibitor of s-nitrosoglutathione reductase (GSNOR), has the potential to be an important new treatment for acute exacerbations of asthma, chronic obstructive pulmonary disease (COPD) and inflammatory bowel disease (IBD). N30 Pharma will now begin a first-in-man, Phase 1, dose escalation trial of N6022 in healthy subjects...” View full resource at qualitypointtech.net
Most Recently Shared on August 5, 2010 at 3:48 pm By:
N30 Pharma Announces FDA Approval To Initiate Phase 1 Clinical Trial For First-in-Class Drug: N30 Pharmaceuticals,... http://bit.ly/dlwMLG
FDA approves new combination asthma therapy
pediatricsupersite.com — “The FDA has recently approved a new fixed-dose combination mometasone furoate and formoterol fumarate dihydrate drug for use in patients aged 12” View full resource at pediatricsupersite.com
Most Recently Shared on June 30, 2010 at 5:49 pm By:
New #asthma treatment, "Many patients may still not be well-controlled on their current therapies": http://ow.ly/25mwv
Medical News: FDA Okays New Drug Combo for Asthma - in Pulmonology, Asthma from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the inhaled corticosteroid/beta2-agonist combination drug mometasone furoate and formoterol fumarate dihydrate (DULERA) for the treatment of asthma in patients 12 an” View full resource at medpagetoday.com
Most Recently Shared on June 28, 2010 at 8:07 pm By:
Medpage Today: FDA Okays New Drug Combo for Asthma http://bit.ly/amLbYr Full http://bit.ly/cS7S75
Asthma inhaler Dulera gets FDA approval - Related Stories - AAP SmartBrief
smartbrief.com — “Merck & Co. obtained FDA approval to sell Dulera, an inhaled asthma treatment for patients age 12 and older. Dulera, which comprises an inhaled corticosteroid and a long-acting beta agonist, is expected to compete with GlaxoSmithKline's Advair. <a href='/servlet/aaRedirect?url2=http%3a%2f%2fwww%2ebi” View full resource at smartbrief.com
Most Recently Shared on June 27, 2010 at 4:09 pm By:
FDA okays Merck's Dulera for asthma - Medical Marketing and Media
mmm-online.com — “FDA approved Merck's Dulera, a combination inhaler, for asthma patients 12 years and older, the company announced today.” View full resource at mmm-online.com
Most Recently Shared on June 25, 2010 at 12:36 pm By:
FDA okays called Dulera for asthma; same line as advair/symbicort: http://bit.ly/dugE43 via @addthis
FDA Approves Merck's Dulera (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older
drugs.com — “Dulera (mometasone furoate and formoterol fumarate dihydrate) is used to treat asthma. Includes Dulera side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 24, 2010 at 10:53 pm By:
FDA Approves Dulera (mometasone/formoterol) Inhalation Aerosol for the treatment of Asthma - http://bit.ly/d0eRIC
Merck says FDA approved its asthma drug Dulera, but it carries slight risk of causing death - Topix
topix.com — “Merck says FDA approved its asthma drug Dulera, but it carries slight risk of causing death - Topix” View full resource at topix.com
Most Recently Shared on June 24, 2010 at 7:45 pm By:
Merck says FDA approved its asthma drug Dulera, but it carries slight risk of causing death: Merck & Co. said Thur... http://bit.ly/axnW6B
Dulera approved for the treatment of asthma - MPR
empr.com — “Merck announced that the FDA has approved Dulera (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 12 years of age.” View full resource at empr.com
Most Recently Shared on June 24, 2010 at 4:07 pm By:
MPR News: Dulera approved for the treatment of asthma: Merck announced that the FDA has approved Dulera (mometason... http://bit.ly/9I0Owb
Seems FDA has approved Merck's new lung drug Dulera but no company statement yet...why? http://www.reuters.com/article/idUSLDE65N0S320100624
reuters.com — “Seems FDA has approved Merck's new lung drug Dulera but no company statement yet...why? http://www.reuters.com/article/idUSLDE65N0S320100624” View full resource at reuters.com
Most Recently Shared on June 24, 2010 at 10:15 am By:
Seems FDA has approved Merck's new lung drug Dulera but no company statement yet...why? http://www.reuters.com/article/idUSLDE65N0S320100624
Advertisement

